Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer
Clinical trial NCT04705649 · COMPLETED
Trial details
- NCT number
- NCT04705649
- Sponsor
- British Columbia Cancer Agency
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2023-06-22
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.